Plasma levels of IL-1Ra are associated with schizophrenia

被引:16
作者
Zhou, Yi [1 ]
Peng, Wu [1 ]
Wang, Jun [1 ]
Zhou, WenJing [1 ]
Zhou, YanHong [1 ]
Ying, BinWu [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
brain-derived neurotrophic factor; cytokine; inflammation; interaction; schizophrenia; CYTOKINE ALTERATIONS; NEUROTROPHIC FACTOR; GROWTH-FACTOR; DUAL ROLE; BRAIN; IMMUNE; IL-1-BETA; BLOOD; BDNF;
D O I
10.1111/pcn.12794
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aim Although peripheral low-grade inflammation and brain-derived neurotrophic factor (BDNF) levels have been implicated in schizophrenia (SCZ), the interactions between them remain to be fully revealed. We aimed to compare BDNF and cytokines in patients with SCZ and healthy controls (HC). Additionally, we aimed to investigate the association between peripheral levels of cytokines and BDNF in patients with SCZ. Methods Plasma levels of BDNF, interferon gamma, interleukin (IL)-10, IL-12, IL-1, IL-6, IL-8, tumor necrosis factor alpha, macrophage migration inhibitory factor, IL-1 receptor antagonist (IL-1Ra), and CD40 Ligand were compared in 45 SCZ patients and 38 HC using Luminex technology. Results Compared to HC, patients had significantly higher IL-1Ra levels (P = 0.031). We found a strong positive association between BDNF and CD40 Ligand in the patient group (rho = 0.858, P < 0.001) as well as in the HC group (rho = 0.822, P < 0.001), respectively. Furthermore, there was a negative association between BDNF and tumor necrosis factor alpha in patients (rho = -0.429, P = 0.030) as well as in HC (rho = -0.649, P < 0.001). Conclusion These results suggest that the cytokine IL-1Ra may play a role in SCZ pathophysiology. Additionally, the interaction between cytokines and BDNF levels further indicated the diverse actions of these cytokines.
引用
收藏
页码:109 / 115
页数:7
相关论文
共 50 条
  • [21] IL-1RA suppresses esophageal cancer cell growth by blocking IL-1α
    Chen, Sui
    Shen, Zhimin
    Liu, Zhun
    Gao, Lei
    Han, Ziyang
    Yu, Shaobin
    Kang, Mingqiang
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2019, 33 (06)
  • [22] Cell therapy centered on IL-1Ra is neuroprotective in experimental stroke
    Bettina Hjelm Clausen
    Kate Lykke Lambertsen
    Frederik Dagnæs-Hansen
    Alicia Anne Babcock
    Christian Ulrich von Linstow
    Michael Meldgaard
    Bjarne Winther Kristensen
    Tomas Deierborg
    Bente Finsen
    Acta Neuropathologica, 2016, 131 : 775 - 791
  • [23] Neuroprotective actions of endogenous interleukin-1 receptor antagonist (IL-1ra) are mediated by glia
    Pinteaux, E
    Rothwell, NJ
    Boutin, H
    GLIA, 2006, 53 (05) : 551 - 556
  • [24] Cell therapy centered on IL-1Ra is neuroprotective in experimental stroke
    Clausen, Bettina Hjelm
    Lambertsen, Kate Lykke
    Dagnaes-Hansen, Frederik
    Babcock, Alicia Anne
    von Linstow, Christian Ulrich
    Meldgaard, Michael
    Kristensen, Bjarne Winther
    Deierborg, Tomas
    Finsen, Bente
    ACTA NEUROPATHOLOGICA, 2016, 131 (05) : 775 - 791
  • [25] Plasma IL-1Ra: linking hyperapoB to risk factors for type 2 diabetes independent of obesity in humans
    Bissonnette, S.
    Saint-Pierre, N.
    Lamantia, V.
    Cyr, Y.
    Wassef, H.
    Faraj, M.
    NUTRITION & DIABETES, 2015, 5 : e180 - e180
  • [26] THE SYNTHESIS OF IL-1 RECEPTOR ANTAGONIST (IL-1RA) BY SYNOVIAL FIBROBLASTS IS MARKEDLY INCREASED BY THE CYTOKINES TNF-ALPHA AND IL-1
    MARTELPELLETIER, J
    MCCOLLUM, R
    PELLETIER, JP
    BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1175 (03) : 302 - 305
  • [27] The effect of an interleukin receptor antagonist (IL-1ra) on colonocyte eicosanoid release
    Smith, GS
    Rieckenberg, C
    Longo, WE
    Kaminski, DL
    Mazuski, JE
    Deshpande, Y
    Miller, TA
    MEDIATORS OF INFLAMMATION, 1996, 5 (06) : 449 - 452
  • [28] IL-1/IL-1ra balance in the brain revisited - Evidence from transgenic mouse models
    Spulber, S.
    Bartfai, T.
    Schultzberg, M.
    BRAIN BEHAVIOR AND IMMUNITY, 2009, 23 (05) : 573 - 579
  • [29] Interleukin-1 receptor antagonist (IL-1RA) and interleukin-4 (IL-4) variable number of tandem repeat polymorphisms in schizophrenia and bipolar disorder: an association study in Turkish population
    Sacide Pehlivan
    Yasemin Oyaci
    Fatima Ceren Tuncel
    Hasan Mervan Aytac
    Egyptian Journal of Medical Human Genetics, 23
  • [30] Interleukin-1 receptor antagonist (IL-1RA) and interleukin-4 (IL-4) variable number of tandem repeat polymorphisms in schizophrenia and bipolar disorder: an association study in Turkish population
    Pehlivan, Sacide
    Oyaci, Yasemin
    Tuncel, Fatima Ceren
    Aytac, Hasan Mervan
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2022, 23 (01)